SurModics Inc. (SRDX) Launches StabilBlot Blocker Family
4/16/2012 10:20:37 AM
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD Inc., a wholly owned subsidiary of SurModics, Inc. (NASDAQ:SRDX) and a market leader for immunoassay reagents for diagnostic tests used to detect the absence or presence of disease, is pleased to announce the launch of StabilBlot™ Blocker Family. The StabilBlot blocker family represents SurModics’ newest offering of its Stabil™ line of quality, market-proven immunodiagnostic reagent products that enhances sensitivity and minimizes background in blotting applications. The StabilBlot Blocker family was initially highlighted at the February 2012 Molecular Tri-Con IVD conference held in San Francisco, CA.